Zobrazeno 1 - 2
of 2
pro vyhledávání: '"William Johnson Irvin"'
Autor:
Meghna S. Trivedi, Joseph M. Unger, Dawn L. Hershman, Amy Darke, Daniel Louis Hertz, Thomas Brannagan, Stephanie Smith, William Johnson Irvin, Amanda Redden Hathaway, Amy C. Vander Woude, Vinay K. Gudena, Norah Lynn Henry, Michael Jordan Fisch
Publikováno v:
Journal of Clinical Oncology. 40:12024-12024
12024 Background: Chemotherapy induced peripheral neuropathy (CIPN) can lead to treatment dose reduction or discontinuation and significantly impact quality of life and functional status. Clinical trials have historically excluded patients with pre-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ca81f8758e4f9b334eaead874f2d107
https://doi.org/10.1200/jco.2022.40.16_suppl.12024
https://doi.org/10.1200/jco.2022.40.16_suppl.12024
Autor:
Wendy Y. Chen, Karla V. Ballman, Eric P. Winer, Thomas H. Openshaw, Olwen Mary Hahn, Frederick M. Briccetti, William Johnson Irvin, Paula R Pohlmann, Lisa A. Carey, Ann H. Partridge, Anna Weiss, Linda Mackie McCall, Carol Matyka, Margaret Carvan, Michelle D. Holmes
Publikováno v:
Journal of Clinical Oncology. 40:360922-360922
360922 Background: In-vitro and in-vivo evidence suggests that aspirin may have an anti-tumor effect. Multiple epidemiologic studies have reported improved breast cancer survival among regular aspirin users compared to non-users. Pooled data from ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::deecede00f8f7305618f8033513587b3
https://doi.org/10.1200/jco.2022.40.36_suppl.360922
https://doi.org/10.1200/jco.2022.40.36_suppl.360922